neurobehavioral therapy

Pear Therapeutics raises $80M; finds cost savings of $2,150 per patient with opioid use disorder

by

Pear Ther­a­peu­tics rais­es $80M in push for reim­burse­ment (Med­C­i­ty News):

Pear Ther­a­peu­tics raised $80 mil­lion in fund­ing, which it plans to use as part of a push for cov­er­age of its dig­i­tal ther­a­peu­tics. The Boston-based com­pa­ny has three FDA-cleared prod­ucts, includ­ing dig­i­tal ther­a­peu­tics for sub­stance use dis­or­der, opi­oid use dis­or­der, and most recent­ly, insom­nia. [Read more…] about Pear Ther­a­peu­tics rais­es $80M; finds cost sav­ings of $2,150 per patient with opi­oid use disorder